Global MicroRNA Market Report

DUBLIN, Apr. 15, 2014 /PRNewswire/ --

Research and Markets

(

http://www.researchandmarkets.com/research/6zn3pr/global_microrna

) has announced the addition of the

"Global MicroRNA Market Report"

report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The analysts forecast the Global MicroRNA market to grow at a CAGR of 17.51 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in microRNA research funding. The Global MicroRNA market has also been witnessing the discovery and development of microRNAs as biomarkers for diseases. However, the high R&D costs could pose a challenge to the growth of this market.

The report, Global MicroRNA Market Report, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers North America, Europe, and the ROW; it also covers the Global MicroRNA market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

A biomarker is a substance or a molecular or cellular process or event that indicates a biological condition. Several research studies have confirmed that

microRNAs

have immense potential as biomarkers for a range of diseases, from cancer to cardiovascular diseases. An increasing number of vendors in the market are focusing on the discovery of microRNA biomarkers for diseases that do not as yet have defined microRNA biomarkers.

For instance, Biogen Idec Inc., a US-based biotechnology company focusing on the development of drugs for the Healthcare sector, and Regulus Therapeutics Inc., a US-based microRNA therapeutics company, have collaborated in their efforts to discover and develop microRNA biomarkers for multiple sclerosis. Thus, the Global MicroRNA market is witnessing the increasing use of microRNAs as biomarkers.

According to the report, one of the most important drivers is the increasing prevalence of diseases such as cancer, which has led to an increase in demand for microRNA-based diagnostic tests.

Key Topics Covered:

01. Executive Summary

02. Scope of the Report

03. Market Research Methodology

04. List of Abbreviations

05. Introduction

06. Market Landscape

07. Global MicroRNA Research Market

08. Global MicroRNA Market

09. Global MicroRNA Market Segmentation

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

19. Key Vendor Analysis

20. Other Reports in this Series


Companies Mentioned:

• Access Pharmaceuticals
• Aegera Therapeutics Inc.
• Affymetrix Inc.
• Agilent Technologies
• Alnylam Pharmaceuticals Inc.
• Antisense Pharma GmbH
• Aparna Biosciences Corp.
• Applied Biological Materials Inc.
• Arrowhead Research Corp.
• AstraZeneca Pharmaceuticals LP
• Asuragen Inc.
• Benitec Biopharma Ltd.
• BioCancell Therapeutics Inc.
• Biogen Idec Inc.
• CBC Comprehensive Biomarker Center GmbH
• Clontech Laboratories Inc.
• Dicerna Pharmaceuticals Inc.
• EMD4Biosciences
• Eli Lilly and Co.
• Exiqon A/S
• Expression Genetics Inc.
• F. Hoffman-La Roche AG
• Fluidigm Corp.
• GeneCopoeia Inc.
• GenoSensor Corp.
• Gensignia Inc.
• GlaxoSmithKline
• Groove Biopharma
• HTG Molecular Diagnostics Inc.
• Idera Pharmaceuticals Inc.
• Illumina Inc.
• InteRNA Technologies B.V.
• Isis Pharmaceuticals Inc.
• LC Sciences Llc
• Life Technologies Corp.
• Merck & Co. Inc.
• Mirna Therapeutics Inc.
• NanoString Technologies Inc.
• Norgen Biotek Corp.
• Novartis AG
• Pfizer Inc.
• Phalanx Biotech Group
• PhaseRx Inc.
• Prolias Technologies Inc.
• Qiagen N.V.
• Quark Pharmaceuticals Inc.
• RXi Pharmaceuticals Corp.
• Regulus Therapeutics Inc.
• Rosetta Genomics Ltd.
• Sanofi U.S.
• Santaris Pharma A/S.
• Sarepta Therapeutics
• Sigma-Aldrich Co. Llc
• Silence Therapeutics Plc
• Sirnaomics Inc.
• Sylentis SA
• Tacere Therapeutics Inc.
• Tekmira Pharmaceuticals Corp.
• Theradiag
• Thermo Fisher Scientific Inc.
• WaferGen Biosystems Inc.
• miRagen Therapeutics Inc.
• siRNAsense AS

For more information visit http://www.researchandmarkets.com/research/6zn3pr/global_microrna

Media Contact: Laura Wood , +353-1-481-1716, [email protected]

SOURCE Research and Markets